TWST logo

Twist Bioscience (TWST)

Profile

Full Name

Twist Bioscience Corporation

Ticker Symbol

TWST

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

October 31, 2018

Indexes

Not included

Website

http://www.twistbioscience.com

Employees

923

Key Details

Price

$38.85(+6.06%)

Market cap

$2.32B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$312.97M(+27.69% YoY)

Annual EPS

-$3.60(0.00% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$38.85
TWST price is $38.85

30-Day Relative Volume

0.86
TWST 30-day relative volume is 0.86

Price Performance

Price Today change

+6.06%
TWST price is up +6.06% today

Price YTD change

-16.4%
TWST price is down -16.4% since January 1st

Price 1-year change

+18.88%
TWST price is up +18.88% year-on-year

Price 3-year change

-11.6%
TWST price is down -11.6% over the past 3 years

Price Range

Price All-time high

$214.07
TWST price is currently -81.85% below its historical high of $214.07

Price 3-year low

$11.46
TWST price is currently +239.01% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.32B
TWST market capitalization is $2.32 billion

Market cap 3-year change

-6.23%
TWST market capitalization is down -6.23% over the past 3 years

Market cap All-time high

$10.11B
TWST market capitalization is currently -77.08% below its historical high of $10.11 billion

Market cap sector rank

84.22%
TWST market capitalization is higher than 84.22% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.56%
TWST shares outstanding is up +2.56% year-on-year

Shares Outstanding 3-Year Change

+6.08%
TWST shares outstanding is up +6.08% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.94
TWST beta is 1.94

200-day SMA

$45.61
TWST price is currently -14.82% below its 200-day simple moving average

50-day SMA

$42.51
TWST price is currently -8.61% below its 50-day simple moving average

RSI

47.61
TWST 14-day relative strength index is 47.61

Volume

0.86
TWST 30-day relative volume is 0.86

ATR

$3.83
TWST average true range is $3.83

10-day Historical Volatility

103.62%
TWST 10-day historical volatility is 103.62%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$312.97M
TWST annual revenue is $312.97 million

Revenue Analysts estimate

$375.82M
TWST annual revenue is currently -16.72% lower than the consensus analysts' forecast

Revenue 1-year change

+27.69%
TWST annual revenue is up +27.69% year-on-year

Revenue Sector rank

69.2%
TWST annual revenue is higher than 69.2% of companies in Healthcare sector

EPS

EPS

-$3.60
TWST annual earnings per share is -$3.60

EPS Analysts estimate

-$2.23
TWST annual earnings per share is currently +61.31% higher than the consensus analysts' forecast

EPS 1-year change

0%
TWST {parameterFullLabel} has remained unchanged year-on-year

EPS Sector rank

24.86%
TWST annual earnings per share is higher than 24.86% of companies in Healthcare sector

Profit

Gross profit

$133.35M
TWST annual gross profit is $133.35 million

Gross margin

42.61%
TWST annual gross profit margin is 42.61%

Operating profit

-$175.90M
TWST annual operating income is -$175.90 million

Operating margin

-56.20%
TWST annual operating profit margin is -56.20%

Net income

-$208.73M
TWST annual net profit is -$208.73 million

Net margin

-66.69%
TWST annual net profit margin is -66.69%

Expenses

Total expenses

$488.88M
TWST annual total expenses is $488.88 million

Operating expenses

$309.25M
TWST annual total operating expenses is $309.25 million

Cost of goods sold

$179.63M
TWST annual cost of goods sold is $179.63 million

Selling, general & administrative expenses

$218.40M
TWST annual SGA is $218.40 million

Depreciation and amortization

$31.43M
TWST annual depreciation & amortization is $31.43 million

Interest expense

$29.00K
TWST annual interest expense is $29.00 thousand

Income tax

$560.00K
TWST annual income tax is $560.00 thousand

EBIT & EBITDA

EBIT

-$208.14M
TWST annual earnings before interest & taxes is -$208.14 million

EBITDA

-$176.71M
TWST annual EBITDA is -$176.71 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$614.32M
TWST annual total assets is $614.32 million

Non current assets

$267.55M
TWST annual long term assets is $267.55 million

Current assets

$346.78M
TWST annual total current assets is $346.78 million

Cash and cash equivalents

$226.32M
TWST annual cash & cash equivalents is $226.32 million

Accounts receivable

$34.90M
TWST annual accounts receivable is $34.90 million

Inventory

$24.08M
TWST annual inventory is $24.08 million

Liabilities

Total liabilities

$141.63M
TWST annual total liabilities is $141.63 million

Long term liabilities

$70.63M
TWST annual total long term liabilities is $70.63 million

Current liabilities

$71.01M
TWST annual total current liabilities is $71.01 million

Accounts payable

$1.63M
TWST annual accounts payable is $1.63 million

Debt

Total debt

$85.03M
TWST annual total debt is $85.03 million

Total debt 1-year change

-9.61%
TWST annual total debt is down -9.61% year-on-year

Long term debt

$70.22M
TWST annual long term debt is $70.22 million

Short term debt

$14.80M
TWST annual short term debt is $14.80 million

Equity & Capital

Shareholders equity

$472.69M
TWST annual stockholders equity is $472.69 million

Book value

$472.69M
TWST annual book value is $472.69 million

Retained earnings

-$1.24B
TWST annual retained earnings is -$1.24 billion

Working capital

$275.77M
TWST annual working capital is $275.77 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$64.09M
TWST annual cash flow from operations is -$64.09 million

Cash from operations 1-year change

+55.01%
TWST annual cash flow from operations is up +55.01% year-on-year

Cash from investing

-$3.07M
TWST annual cash flow from investing activities is -$3.07 million

Cash from investing 1-year change

-106.07%
TWST annual cash flow from investing activities is down -106.07% year-on-year

Cash from financing

$6.89M
TWST annual cash flow from financing activities is $6.89 million

Cash from financing 1-year change

+656.31%
TWST annual cash flow from financing activities is up +656.31% year-on-year

CAPEX

CAPEX

$5.08M
TWST annual capital expenditures is $5.08 million

CAPEX 1-year change

-81.73%
TWST annual capital expenditures is down -81.73% year-on-year

Free Cash Flow

Free cash flow

-$69.17M
TWST annual free cash flow is -$69.17 million

Free cash flow 1-year change

+59.37%
TWST annual free cash flow is up +59.37% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

42.61%
TWST annual gross profit margin is 42.61%

Operating margin

-56.20%
TWST annual operating profit margin is -56.20%

Net margin

-66.69%
TWST annual net profit margin is -66.69%

ROA & ROE

ROA

-30.02%
TWST annual return on assets is -30.02%

ROE

-38.08%
TWST annual return on equity is -38.08%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TWST price to earnings ratio value is unknown

PE ratio Sector rank

-
TWST price to earnings ratio is unknown

PB Ratio

PB ratio

5.08
TWST price to book ratio is 5.08

PB ratio Sector rank

84.05%
TWST price to book ratio is higher than 84.05% of companies in Healthcare sector

PS Ratio

PS ratio

7.02
TWST price to sales ratio is 7.02

PS ratio Sector rank

73.72%
TWST price to sales ratio is higher than 73.72% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.18B
TWST enterprise value is $2.18 billion

Enterprise value Sector rank

83.1%
TWST enterprise value is higher than 83.1% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-13.04
TWST EV/EBITDA is -13.04

EV/EBITDA Sector rank

8.94%
TWST EV/EBITDA is higher than 8.94% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.88
TWST annual current ratio is 4.88

Quick ratio

4.54
TWST annual quick ratio is 4.54

Leverage

Debt to equity

0.00
TWST annual debt to equity ratio is 0.00

Interest coverage ratio

-7177.14
TWST annual interest coverage ratio is -7177.14

Risk & Stability

Piotroski F-Score

4
TWST piotroski f-score is 4

Altman Z-Score

6.92
TWST altman z-score is 6.92

Analyst ratings

Recent major analysts updates

Feb 4, 25 Scotiabank
Sector Outperform
Feb 4, 25 JP Morgan
Underweight
Feb 4, 25 Baird
Outperform
Dec 13, 24 Wolfe Research
Outperform
Nov 26, 24 TD Cowen
Buy
Nov 19, 24 Scotiabank
Sector Outperform
Nov 19, 24 Barclays
Overweight
Nov 19, 24 Baird
Outperform
Oct 17, 24 Leerink Partners
Market Perform
Oct 1, 24 Evercore ISI Group
Outperform

Institutional Ownership

Similar stocks

RXRX logo
Recursion Pharmaceuticals (RXRX)
AGL logo
agilon health (AGL)
HCM logo
HUTCHMED (China) Limited (HCM)
IBRX logo
ImmunityBio (IBRX)
XENE logo
Xenon Pharmaceuticals (XENE)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
ACHC logo
Acadia Healthcare (ACHC)
ACAD logo
ACADIA Pharmaceuticals (ACAD)
APLS logo
Apellis Pharmaceuticals (APLS)
  • What is the ticker symbol for Twist Bioscience?
  • Does Twist Bioscience pay dividends?
  • What sector is Twist Bioscience in?
  • What industry is Twist Bioscience in?
  • What country is Twist Bioscience based in?
  • When did Twist Bioscience go public?
  • Is Twist Bioscience in the S&P 500?
  • Is Twist Bioscience in the NASDAQ 100?
  • Is Twist Bioscience in the Dow Jones?
  • When was Twist Bioscience's last earnings report?
  • When does Twist Bioscience report earnings?
  • Should I buy Twist Bioscience stock now?

What is the ticker symbol for Twist Bioscience?

The ticker symbol for Twist Bioscience is NASDAQ:TWST

Does Twist Bioscience pay dividends?

No, Twist Bioscience does not pay dividends

What sector is Twist Bioscience in?

Twist Bioscience is in the Healthcare sector

What industry is Twist Bioscience in?

Twist Bioscience is in the Diagnostics & Research industry

What country is Twist Bioscience based in?

Twist Bioscience is headquartered in United States

When did Twist Bioscience go public?

Twist Bioscience's initial public offering (IPO) was on October 31, 2018

Is Twist Bioscience in the S&P 500?

No, Twist Bioscience is not included in the S&P 500 index

Is Twist Bioscience in the NASDAQ 100?

No, Twist Bioscience is not included in the NASDAQ 100 index

Is Twist Bioscience in the Dow Jones?

No, Twist Bioscience is not included in the Dow Jones index

When was Twist Bioscience's last earnings report?

Twist Bioscience's most recent earnings report was on Feb 3, 2025

When does Twist Bioscience report earnings?

The next expected earnings date for Twist Bioscience is May 2, 2025

Should I buy Twist Bioscience stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page